@360DxNews PRESS RELEASE - MyCartis and XVIVO Perfusion AB engage to develop a fast #diagnostic test to assess the quality of #donated#organs before #transplantation
Read the full article: https://t.co/s7Uadn427q
PRESS RELEASE - MyCartis and XVIVO Perfusion AB engage to develop a fast #diagnostic test to assess the quality of #donated#organs before #transplantation Read the full article: https://t.co/s7Uadn427q
@BioVoxBelgium Saving lives by making more donor organs available for successful transplantation. Read MyCartis' White Paper on this topic.
Download your copy: https://t.co/mcqTnDv3Fi
@360DxNews Saving lives by making more donor organs available for successful transplantation. Read MyCartis' White Paper on this topic.
Download your copy: https://t.co/mcqTnDv3Fi
@Labiotech_eu Saving lives by making more donor organs available for successful transplantation. Read MyCartis' White Paper on this topic.
Download your copy: https://t.co/mcqTnDv3Fi
Saving lives by making more donor organs available for successful transplantation. Read MyCartis' White Paper on this topic.
Download your copy: https://t.co/mcqTnDv3Fi
@BioVoxBelgium MyCartis to engage in point-of-need testing with the ANTELOPE Dx platform technology: Clinical lab performance with the ease-of-use of a pregnancy test - https://t.co/024vpTaUD4
@FierceBiotech MyCartis to engage in point-of-need testing with the ANTELOPE Dx platform technology: Clinical lab performance with the ease-of-use of a pregnancy test - https://t.co/024vpTaUD4
@360DxNews MyCartis to engage in point-of-need testing with the ANTELOPE Dx platform technology: Clinical lab performance with the ease-of-use of a pregnancy test - https://t.co/024vpTaUD4
@Labiotech_eu MyCartis to engage in point-of-need testing with the ANTELOPE Dx platform technology: Clinical lab performance with the ease-of-use of a pregnancy test - https://t.co/024vpTaUD4
@GenomeWeb MyCartis to engage in point-of-need testing with the ANTELOPE Dx platform technology: Clinical lab performance with the ease-of-use of a pregnancy test - https://t.co/024vpTaUD4
Visit @MyCartis at #Kfg2018 organized by @flandersbio booth 67. MyCartis' #EVALUTION® leverages high quality analytical performance from conventional #immunodiagnostic approaches with the unique capability to quantify and monitor binding reactions in real-time.
MyCartis' #EVALUTION® leverages high quality analytical performance from conventional #immunodiagnostic approaches with the unique capability to quantify and monitor binding reactions in real-time. Visit our new website https://t.co/0tmigR69eC
@MyCartis has moved to its new office! You can reach us via our new phone number +32 9 2779 888 and we are located at Industriezone Zwijnaarde 7C, B-9052 Zwijnaarde, Belgium, in the new Bioscape buildings (https://t.co/eFWVgPU8yh)
@MyCartis@medica2017 HALL 3 / booth J74 - optimized binding kinetics and binding reactions can be followed in real-time - #DMAT® provides the perfect platform to assess binding interactions and hence the potency and avidity of the #protein-#antibody interaction. #diagnostics